4D Pharma PLC (NASDAQ: LBPS)
|
|
---|---|
Pricing data not available |
Open: | $ n/a | Volume: | n/a | |
---|---|---|---|---|
High: | $ n/a | Yield(%) | n/a | |
Low: | $ n/a | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | n/a | |
EPS ($) | n/a | Shares Out: | n/a |
% Price Change (last 4 weeks): | 0.00 |
---|---|
% Price Change (last 13 weeks): | 0.00 |
% Price Change (last 26 weeks): | 0.00 |
% Price Change (last 52 weeks): | 0.00 |
% Price Change (year to date): | -70.43 |
Return on Equity (%): | -213.09 |
---|---|
Return on Assets (%): | -139.26 |
Return on Invested Capital (%): | -113.04 |
Gross Profit Margin (%): | n/a |
---|---|
Net Profit Margin (%): | -10337.16 |
Operating Profit Margin (%): | -5089.08 |
|
|
50-day Moving Average: | $n/a |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | n/a |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $n/a |
52-wk low: | $n/a |
Bid: | $n/a |
Ask: | $n/a |
4D Pharma Plc is a pharmaceutical company, which engages in the development of live bio therapeutics. It focuses on the research of Microbiome, MicroRx, and MicroDx its proprietary platforms for the discovery of novel live bio therapeutics and the development of its pipeline. The company was founded by Duncan Joseph Peyton on January 10, 2014 and is headquartered in Leeds, the United Kingdom.
|
4D Pharma PLC
9 Bond Court 5th Floor Leeds YO LS1 2JZ Phone: 44.113.895.0130 Fax: n/a http://www.4dpharmaplc.com |
Earnings (1year) ($): | -3.80 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 1.39 |
Cash Flow ($): | -3.23 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 160.86 |
Price/Book (x): | 3.91 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 5.16 |
---|---|
Current Ratio (x): | 5.21 |
LT Debt/Equity (x): | 42.46 |
Total Debt/Equity (x): | 42.81 |